Jennifer A. Silver

McGill University Health Centre, McGill University

Papers

Total Citations

H-Index

About

Jennifer A. Silver is a surgical oncologist whose research focuses on improving quality of life for patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma (HPV-OPSCC). Her work centers on de-intensifying treatment protocols—specifically through neoadjuvant chemotherapy followed by transoral robotic surgery (TORS)—to reduce the severe, long-term toxicities of traditional radiation-based therapies while preserving excellent oncologic outcomes. Her 2023 study on quality of life after this combined approach, which has garnered 13 citations, provides critical evidence that TORS-based de-escalation can significantly diminish swallowing difficulties, xerostomia, and other treatment-related adverse effects. A subsequent 2024 descriptive study further characterizes these QOL benefits, reinforcing the potential to shift the standard of care for early-stage HPV-OPSCC. Silver’s contributions are particularly impactful in an era where overtreatment remains a major concern; her findings offer a patient-centered roadmap for balancing cure with survivorship. By demonstrating that surgical de-intensification can maintain high survival rates while sparing patients from lifelong morbidity, she is helping redefine treatment paradigms for a growing population of younger, healthier HPV-positive patients.